http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017099413-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02ac9bd35856d8efcae5699b55f9a19c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9789 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-97 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 |
| filingDate | 2016-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e26c0cfc65ff27d34f69667f4bde5a88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9e3b9848534ee6bcbcab75261b64cdb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a18d54ef1288d49e41dbbcbc078e173 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_178603fcf9588f45169801f6324dc93d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd1be8a85f64adc4646d6f29365d0925 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7add821933d610019f6dc76bc811a64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07fc07403a3cd40e95d5db63cef2244c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13959e65db79be3e60a41318d8c70861 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_164f2f3ca81bbbf342955163bfafceb8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea882152d69d19fd9819d95f13fd2d70 |
| publicationDate | 2017-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2017099413-A1 |
| titleOfInvention | Composition comprising enzyme-treated rosa multiflora fruit extract as active ingredient for preventing or treating th2-mediated immunological disease |
| abstract | The present invention relates to a composition comprising an enzyme-treated Rosa multiflora fruit extract as an active ingredient for preventing or treating a Th2-mediated immune disease. The composition according to the present invention can maximize the anti-allergic effect of the Rosa multiflora fruit extract by comprising an enzyme-treated Rosa multiflora fruit extract as an active ingredient. Specifically, the present inventors verified that, as a result of treating splenocytes of OVA-immunized mice with an enzyme-treated Rosa multiflora fruit extract, the enzyme-treated Rosa multiflora fruit extract remarkably promoted IL-4 production inhibitory activity compared with an enzyme-non-treated Rosa multiflora fruit extract and the in vivo oral administration of the enzyme-treated Rosa multiflora fruit extract remarkably reduced the blood IgE content in the OVA-immunized mice. In addition, the composition according to the present invention has advantages of being biocompatible and having excellent stability due to the use of Rosa multiflora fruit as a natural material, and thus, the composition is expected to be favorably used in the development of a safe therapeutic agent, a health functional food, a cosmetic product, and the like for the prevention, improvement, or treatment of a Th2-mediated immune disease. |
| priorityDate | 2015-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 243.